Jpmorgan Chase & CO Illumina, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Illumina, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 674,009 shares of ILMN stock, worth $64.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

674,009

Previous 791,080 14.8%

Holding current value

$64.1 Million

Previous $106 Million 49.41%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$79.34 - $144.22 $9.29 Million - $16.9 Million	-117,071 Reduced 14.8%	674,009 $53.5 Million
Q4 2024 Feb 12, 2025	BUY	$128.99 - $155.15 $18.1 Million - $21.8 Million	140,666 Added 21.63%	791,080 $106 Million
Q3 2024 Dec 26, 2024	BUY	$105.28 - $135.9 $1.58 Million - $2.04 Million	15,011 Added 2.36%	650,414 $84.8 Million
Q3 2024 Nov 08, 2024	BUY	$105.28 - $135.9 $1.58 Million - $2.04 Million	15,011 Added 2.36%	650,414 $84.8 Million
Q2 2024 Dec 26, 2024	SELL	$101.05 - $133.57 $1.52 Million - $2.01 Million	-15,011 Reduced 2.31%	635,403 $66.3 Million
Q2 2024 Aug 12, 2024	SELL	$101.05 - $133.57 $50.5 Million - $66.7 Million	-499,275 Reduced 44.0%	635,403 $66.3 Million
Q1 2024 Dec 26, 2024	BUY	$127.73 - $147.2 $61.9 Million - $71.3 Million	484,264 Added 74.45%	1,134,678 $156 Million
Q1 2024 May 10, 2024	BUY	$127.73 - $147.2 $63.3 Million - $73 Million	495,853 Added 77.62%	1,134,678 $156 Million
Q4 2023 Dec 26, 2024	SELL	$92.79 - $142.53 $1.08 Million - $1.65 Million	-11,589 Reduced 1.78%	638,825 $88.9 Million
Q4 2023 Feb 12, 2024	BUY	$92.79 - $142.53 $5.03 Million - $7.72 Million	54,194 Added 9.27%	638,825 $88.9 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $14.3 Million - $21.3 Million	110,745 Added 23.37%	584,631 $80.3 Million
Q2 2023 Aug 11, 2023	SELL	$183.43 - $232.67 $88.6 Million - $112 Million	-483,189 Reduced 50.49%	473,886 $88.8 Million
Q1 2023 May 18, 2023	BUY	$193.75 - $232.55 $14.3 Million - $17.2 Million	74,031 Added 8.38%	957,075 $223 Million
Q1 2023 May 11, 2023	BUY	$193.75 - $232.55 $54.1 Million - $64.9 Million	279,263 Added 46.25%	883,044 $205 Million
Q4 2022 Feb 13, 2023	BUY	$187.24 - $242.74 $40.6 Million - $52.6 Million	216,856 Added 56.05%	603,781 $122 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $5.54 Million - $7.1 Million	31,235 Added 8.78%	386,925 $73.8 Million
Q2 2022 Aug 11, 2022	SELL	$181.58 - $368.0 $35.9 Million - $72.8 Million	-197,916 Reduced 35.75%	355,690 $65.6 Million
Q1 2022 May 11, 2022	BUY	$303.87 - $423.8 $58.4 Million - $81.5 Million	192,337 Added 53.24%	553,606 $193 Million
Q4 2021 Feb 10, 2022	SELL	$347.28 - $421.83 $53.8 Million - $65.4 Million	-155,008 Reduced 30.02%	361,269 $137 Million
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $209 Million - $271 Million	516,277 New	516,277 $209 Million

Others Institutions Holding ILMN

# of Institutions

864

Shares Held

153M

Call Options Held

6.88M

Put Options Held

1.1M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $14.9B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Illumina, Inc. Transaction History